Ambryon Biosciences

AAV2-7M8 Serotype

Engineered AAV2 variant selected through directed evolution in human hepatocyte xenograft mice. Contains a seven-amino acid insertion at position 588 in the capsid.

TropismLiver (human hepatocytes), enhanced human-specific transduction

Characteristics

20-fold enhanced human hepatocyte transduction versus wild-type AAV2. Demonstrates species-specific tropism improvements. Selected using humanized mouse model platform. Seven-amino acid peptide insertion (LALGETTRP) at capsid position 588.

Applications

Liver-directed gene therapy for metabolic disorders. Hemophilia A and B. Preclinical model for humanized AAV evolution strategies.

Sequence1 bp

Sign in to view the full sequence.

Sign in

References

  1. 1.Lisowski et al. (2014). Selection and evaluation of clinically relevant AAV variants in a xenograft liver model. Nature — Lisowski 2014 AAV2-7m8

Identifiers & revision